Showing results (1281-1290 of 4,565) with videos related to

Sort By:
Pageof 457
Advances in Therapy|July 25, 2023
People Diagnosed with Myasthenia Gravis have Lower health-related quality of life and Need More Medical and Caregiver Help in Comparison to the General Population: Analysis of Two Observational StudiesS Dewilde, G Phillips, S Paci, et al.
Advances in Therapy|July 15, 2023
Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover StudyMasaru Inatani, Yusuke Orii, Kentaro Iwasaki, et al.
Advances in Therapy|July 11, 2023
A Podcast Discussion on the Current Treatment Landscape for Renal Cell CarcinomaPhilipp Ivanyi, Jonas Paul Wiegmann, Hendrik Eggers, et al.
Advances in Therapy|July 25, 2023
Remimazolam Compared to Propofol for Total Intravenous Anesthesia with Remifentanil on the Recovery of Psychomotor Function: A Randomized Controlled TrialTakahito Shimizu, Toshifumi Takasusuki, Shigeki Yamaguchi
Advances in Therapy|July 25, 2023
Real-World Outcomes of Trilaciclib Among Patients with Extensive-Stage Small Cell Lung Cancer Receiving ChemotherapyJerome Goldschmidt, Lowell Hart, Jeffrey Scott, et al.
Advances in Therapy|June 27, 2023
Narrative Review of Topiramate: Clinical Uses and Pharmacological ConsiderationsNathan Z Pearl, Caroline P Babin, Nicole T Catalano, et al.
Advances in Therapy|June 27, 2023
Real-World Evaluation of the Management, Treatment Pathways and Outcome of Melanoma Patients with Target Therapies in ItalyIlaria Gioia Marcon, Diletta Valsecchi, Lorenza Durso, et al.
Advances in Therapy|June 28, 2023
Characterizing Opioid Use Disorder Encounters in the Midwest Region, USAYifei Liu, Suman Sahil, Stacy L Farr, et al.
Advances in Therapy|July 26, 2023
Global Economic Burden Associated with Chronic Kidney Disease: A Pragmatic Review of Medical Costs for the Inside CKD Research ProgrammeVivekanand Jha, Saeed M G Al-Ghamdi, Guisen Li, et al.
Advances in Therapy|July 29, 2023
Cost-Effectiveness of Newer Antidiabetic Drugs as Second-Line Treatment for Type 2 Diabetes: A Systematic ReviewJiejin Zhu, Ying Zhou, Qingyu Li, et al.
Pageof 457